Clinical Trial Update: Phase II Trial of Erlotinib in Advanced Pancreatic Cancer [Phase 2]

View source ↗

Summary

Phase II trial results for Erlotinib in advanced pancreatic cancer have been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• ERLOTINIB (Erlotinib)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Cancer, Pancreas | Phase 2 | Status: COMPLETED